1-9 of 9
Ganesan Vaidyanathan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4213: Gold nanostar as theranostic probe for brain tumor sensitive PET-optical imaging and image-guided specific photothermal therapy

Yang Liu, Austin Carpenter, Hsiangkuo Yuan, Zhengyuan Zhou, Michael Zalutsky, Ganesan Vaidyanathan, Hai Yan, Tuan Vo-Dinh
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4213.
https://doi.org/10.1158/1538-7445.AM2016-4213
Published: 15 July 2016
View article titled, Abstract 4213: Gold nanostar as theranostic probe for brain tumor sensitive PET-optical imaging and image-guided specific photothermal therapy
Journal Articles

Abstract 1610: Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma

Vandana Batra, Pietro Ranieri, Mehran Makvandi, Matthew Tsang, Catherine Hou, Yimei Li, Ganesan Vaidyanathan, Daniel A. Pryma, John M. Maris
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1610.
https://doi.org/10.1158/1538-7445.AM2015-1610
Published: 01 August 2015
View article titled, Abstract 1610: Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma
Journal Articles

Targeted drug delivery for neuroblastoma using MIBG.

Michael P. Gamcsik, James B. Springer, Timothy A. Driscoll, Ganesan Vaidyanathan, O. Michael Colvin, Susan M. Ludeman
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1345.
Published: 15 April 2006
View article titled, Targeted drug delivery for neuroblastoma using MIBG.
Journal Articles

Anti-EGFRvIII minibody (MR1-1scFv-CH3) targeting of human glioma xenografts

Chien-Tsun Kuan, Ganesan Vaidyanathan, Michael R. Zalutsky, Ira Pastan, Darell D. Bigner
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 160–161.
Published: 01 April 2004
View article titled, Anti-EGFRvIII minibody (MR1-1scFv-CH3) targeting of human glioma xenografts
Journal Articles

4-Guanidinomethyl-3-[131I]iodobenzoyl-Phe1-octreotate ([131I]GMIBO)and 3-[211At]astato-4-guanidinomethylbenzoyl-Phe1-octreotate ([211At]AGMBO): Potential agents for the radiotherapy of somatostatin receptor-positive tumors

Ganesan Vaidyanathan, Abraham Boskovitz, Donna J. Affleck, Michael R. Zalutsky
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 231.
Published: 01 April 2004
View article titled, 4-Guanidinomethyl-3-[<sup>131</sup>I]iodobenzoyl-Phe<sup>1</sup>-octreotate ([<sup>131</sup>I]GMIBO)and 3-[<sup>211</sup>At]astato-4-guanidinomethylbenzoyl-Phe<sup>1</sup>-octreotate ([<sup>211</sup>At]AGMBO): Potential agents for the radiotherapy of somatostatin receptor-positive tumors
Journal Articles

Synthesis and in vitro evaluation of O6-3[131/125I]iodobenzyl-2′-deoxyguanosine ([131/125I]IBdG), a potential agent for the quantification of alkylguanine-DNA alkyltransferase (AGT)

Sriram Shankar, Donna J. Affleck, Philip C. Welsh, Michael R. Zalutsky, Ganesan Vaidyanathan
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 231–232.
Published: 01 April 2004
View article titled, Synthesis and <em>in vitro</em> evaluation of <em>O</em><sup>6</sup>-3[<sup>131/125</sup>I]iodobenzyl-2′-deoxyguanosine ([<sup>131/125</sup>I]IBdG), a potential agent for the quantification of alkylguanine-DNA alkyltransferase (AGT)
Journal Articles

5-[211At]Astato-2′-deoxyuridine, an α-Particle-emitting Endoradiotherapeutic Agent Undergoing DNA Incorporation

Ganesan Vaidyanathan, Roy H. Larsen, Michael R. Zalutsky
Journal: Cancer Research
Cancer Res (1996) 56 (6): 1204–1209.
Published: 01 March 1996
View article titled, 5-[<sup>211</sup>At]Astato-2′-deoxyuridine, an α-Particle-emitting Endoradiotherapeutic Agent Undergoing DNA Incorporation
Open the PDF for 5-[<sup>211</sup>At]Astato-2′-deoxyuridine, an α-Particle-emitting Endoradiotherapeutic Agent Undergoing DNA Incorporation in another window
Journal Articles

Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts

Craig J. Reist, Gary E. Archer, Shekar N. Kurpad, Carol J. Wikstrand, Ganesan Vaidyanathan, Mark C. Willingham, David K. Moscatello, Albert J. Wong, Darell D. Bigner, Michael R. Zalutsky
Journal: Cancer Research
Cancer Res (1995) 55 (19): 4375–4382.
Published: 01 October 1995
View article titled, Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts
Open the PDF for Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts in another window
Journal Articles

Cytotoxicity of α-Particle-emitting m-[211At]Astatobenzylguanidine on Human Neuroblastoma Cells

Donald K. Strickland, Ganesan Vaidyanathan, Michael R. Zalutsky
Journal: Cancer Research
Cancer Res (1994) 54 (20): 5414–5419.
Published: 01 October 1994
View article titled, Cytotoxicity of α-Particle-emitting <em>m</em>-[<sup>211</sup>At]Astatobenzylguanidine on Human Neuroblastoma Cells
Open the PDF for Cytotoxicity of α-Particle-emitting <em>m</em>-[<sup>211</sup>At]Astatobenzylguanidine on Human Neuroblastoma Cells in another window